Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2021 07:00 ET | Source: Avisa Diagnostics Inc.

Avisa Diagnostics Retains Venture Liquidity Providers Inc. for Market-Making Services

SANTA FE, N.M., May 26, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for...
May 18, 2021 07:00 ET | Source: Avisa Diagnostics Inc.

Avisa Diagnostics Begins Trading on the Canadian Securities Exchange

Public Listing offers Access to CAD 52 Million from Share Subscription and Drawdown Agreement, Sufficient Funding to Complete Development and Launch Avisa BreathTest™Pivotal Trials Planned in...
May 04, 2021 14:14 ET | Source: Avisa Diagnostics Inc.

Avisa Diagnostics Inc. (Formerly, FogChain Corp.) Announces Closing of Reverse Takeover Transaction

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N. M., May 04, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (formerly, FogChain...
September 18, 2018 08:30 ET | Source: Avisa Pharma Inc.

Avisa Reports on Progress with Biomarker AV BreathTest™ Platform

Ten-minute, point-of-care breath test rapidly detects virulent bacterial infections to mitigate overuse of antibiotics and save hospital costsProof-of-concept trial in Emergency Department pneumonia...